000702.SZ
Hunan Zhenghong Science and Technology Develop Co.,Ltd. [000702.SZ] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
000702.SZ Stock Summary
Top 10 Correlated ETFs
000702.SZ
Top 10 Correlated Stocks
000702.SZ
In the News
000702.SZ Financial details
Company Rating
Buy
Market Cap
1.38B
Income
-136.97M
Revenue
1.23B
Book val./share
0.75
Cash/share
0.47
Dividend
-
Dividend %
-
Employees
1.01K
Optionable
No
Shortable
Yes
Earnings
28 Apr 2021
P/E
-10.08
Forward P/E
-
PEG
1.37
P/S
1.12
P/B
6.87
P/C
11.02
P/FCF
-29.86
Quick Ratio
0.19
Current Ratio
0.5
Debt / Equity
3.45
LT Debt / Equity
0.15
-
-
EPS (TTM)
-0.33
EPS next Y
-
EPS next Q
-
EPS this Y
-53.6%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
NAN%
Revenue last 5Y
-2.85%
Revenue Q/Q
-10.84%
EPS Q/Q
-
-
-
-
-
SMA20
3.96%
SMA50
-12.79%
SMA100
-8.85%
Inst Own
-
Inst Trans
-
ROA
-18%
ROE
-57%
ROC
-1%
Gross Margin
3%
Oper. Margin
-9%
Profit Margin
-11%
Payout
-14%
Shs Outstand
266.64M
Shs Float
198.57M
-
-
-
-
Target Price
-
52W Range
4.82-8.09
52W High
-35.25%
52W Low
+29.5%
RSI
44.47
Rel Volume
0.68
Avg Volume
6.46M
Volume
4.4M
Perf Week
-1.33%
Perf Month
-0.38%
Perf Quarter
-15.91%
Perf Half Y
-13.81%
-
-
-
-
Beta
0.51192
-
-
Volatility
0.04%, 0.11%
Prev Close
-1.33%
Price
5.18
Change
-1.33%
000702.SZ Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-12-31
| Metric | History | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 |
|---|---|---|---|---|---|---|
| Revenue per share | 5.03 | 4.21 | 4.01 | 5.37 | 4.35 | |
| Net income per share | 0.21 | 0.06 | 0.13 | -1.25 | -0.58 | |
| Operating cash flow per share | 0.04 | 0.34 | -0.42 | -0.48 | -0.3 | |
| Free cash flow per share | -0.12 | 0.16 | -1.03 | -0.92 | -0.46 | |
| Cash per share | 0.27 | 0.49 | 0.26 | 0.38 | 0.29 | |
| Book value per share | 1.95 | 2.02 | 2.18 | 1.31 | 0.86 | |
| Tangible book value per share | 1.88 | 1.98 | 2.22 | 0.94 | 0.34 | |
| Share holders equity per share | 1.95 | 2.02 | 2.18 | 1.31 | 0.86 | |
| Interest debt per share | 0.18 | 0.1 | 0.51 | 1.86 | 1.89 | |
| Market cap | 1.45B | 1.54B | 1.56B | 1.33B | 1.51B | |
| Enterprise value | 1.42B | 1.46B | 1.63B | 1.71B | 1.92B | |
| P/E ratio | 25.97 | 100.2 | 46.42 | -4.01 | -9.73 | |
| Price to sales ratio | 1.08 | 1.37 | 1.46 | 0.93 | 1.3 | |
| POCF ratio | 133.11 | 16.7 | -13.87 | -10.35 | -18.73 | |
| PFCF ratio | -44.58 | 36.52 | -5.69 | -5.45 | -12.43 | |
| P/B Ratio | 2.78 | 2.85 | 2.68 | 3.8 | 6.64 | |
| PTB ratio | 2.78 | 2.85 | 2.68 | 3.8 | 6.64 | |
| EV to sales | 1.06 | 1.3 | 1.53 | 1.19 | 1.66 | |
| Enterprise value over EBITDA | 13.94 | 30.09 | 38.52 | -308.81 | -51.9 | |
| EV to operating cash flow | 130.68 | 15.89 | -14.52 | -13.25 | -23.77 | |
| EV to free cash flow | -43.77 | 34.75 | -5.95 | -6.97 | -15.77 | |
| Earnings yield | 0.04 | 0.01 | 0.02 | -0.25 | -0.1 | |
| Free cash flow yield | -0.02 | 0.03 | -0.18 | -0.18 | -0.08 | |
| Debt to equity | 0.38 | 0.22 | 0.52 | 1.78 | 2.98 | |
| Debt to assets | 0.27 | 0.18 | 0.33 | 0.69 | 0.85 | |
| Net debt to EBITDA | -0.26 | -1.54 | 1.71 | -67.67 | -11.01 | |
| Current ratio | 1.8 | 2.44 | 1.46 | 0.67 | 0.53 | |
| Interest coverage | 2.81 | 10.19 | 4.18 | -4.14 | -4.71 | |
| Income quality | 0.2 | 6 | -3.39 | 0.39 | 0.52 | |
| Dividend Yield | 0 | 0 | 0 | 0.01 | 0.01 | |
| Payout ratio | 0.05 | 0.13 | 0.06 | -0.05 | -0.11 | |
| Sales general and administrative to revenue | 0.01 | 0.02 | 0.02 | 0.02 | 0.02 | |
| Research and developement to revenue | 0.01 | 0 | 0.01 | 0 | 0.01 | |
| Intangibles to total assets | 0.03 | 0.05 | 0.03 | 0.03 | 0.03 | |
| Capex to operating cash flow | -3.99 | -0.54 | 1.44 | 0.9 | 0.51 | |
| Capex to revenue | -0.03 | -0.04 | -0.15 | -0.08 | -0.04 | |
| Capex to depreciation | -1.62 | -1.77 | -4.25 | -1.37 | -0.58 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 3.03 | 1.62 | 2.48 | 6.08 | 3.35 | |
| ROIC | 0.01 | 0.04 | 0 | -0.13 | -0.17 | |
| Return on tangible assets | 0.08 | 0.02 | 0.04 | -0.38 | -0.2 | |
| Graham Net | -0.14 | 0.26 | -0.3 | -1.52 | -1.85 | |
| Working capital | 145.9M | 154.25M | 134.91M | -171.59M | -298.66M | |
| Tangible asset value | 502.03M | 527.5M | 591.17M | 251.35M | 91.06M | |
| Net current asset value | 131.56M | 141.14M | 122.81M | -272.97M | -343.19M | |
| Invested capital | 0.09 | 0.05 | 0.23 | 1.36 | 2.12 | |
| Average receivables | 0 | 0 | 0 | 0 | 0 | |
| Average payables | 80.97M | 51.14M | 49.74M | 75.54M | 87.87M | |
| Average inventory | 186.58M | 146.45M | 213.61M | 267.93M | 223.95M | |
| Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
| Days payables outstanding | 21.53 | 11.02 | 27.04 | 21.3 | 30.11 | |
| Days of inventory on hand | 51.57 | 44.17 | 119.41 | 59.65 | 70.21 | |
| Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
| Payables turnover | 16.95 | 33.11 | 13.5 | 17.14 | 12.12 | |
| Inventory turnover | 7.08 | 8.26 | 3.06 | 6.12 | 5.2 | |
| ROE | 0.11 | 0.03 | 0.06 | -0.95 | -0.68 | |
| Capex per share | -0.16 | -0.19 | -0.61 | -0.43 | -0.15 |
Quarterly Fundamentals Overview
Last date of statement is 2023-03-31 for Q1
| Metric | History | 2022-03-31 | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 |
|---|---|---|---|---|---|---|
| Revenue per share | 0.82 | 1.04 | 1.27 | 0 | 1.08 | |
| Net income per share | -0.23 | -0.13 | -0.04 | 0 | -0.16 | |
| Operating cash flow per share | 0 | 0 | 0 | 0 | 0 | |
| Free cash flow per share | 0 | -0.1 | -0.02 | 0 | -0.02 | |
| Cash per share | 0.23 | 0.39 | 0.37 | 0 | 0.47 | |
| Book value per share | 1.13 | 1.02 | 0.99 | 0 | 0.75 | |
| Tangible book value per share | 0.7 | 0.57 | 0.52 | 0 | 0.19 | |
| Share holders equity per share | 1.13 | 1.02 | 0.99 | 0 | 0.75 | |
| Interest debt per share | 1.71 | 1.94 | 1.91 | 0 | 1.69 | |
| Market cap | 1.5B | 1.44B | 1.56B | 0 | 1.49B | |
| Enterprise value | 1.89B | 1.85B | 1.96B | 407.58M | 1.81B | |
| P/E ratio | -6.07 | -10.24 | -35.81 | 0 | -8.67 | |
| Price to sales ratio | 6.83 | 5.2 | 4.59 | 0 | 5.17 | |
| POCF ratio | 0 | 0 | 0 | 0 | 0 | |
| PFCF ratio | -1.58K | -55.44 | -299.18 | 0 | -239.96 | |
| P/B Ratio | 4.99 | 5.3 | 5.92 | 0 | 7.43 | |
| PTB ratio | 4.99 | 5.3 | 5.92 | 0 | 7.43 | |
| EV to sales | 8.61 | 6.67 | 5.78 | 1.26 | 6.28 | |
| Enterprise value over EBITDA | -34.52 | -58.36 | -665.86 | -22.52 | -74.36 | |
| EV to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
| EV to free cash flow | -2K | -71.16 | -376.86 | -46.51 | -291.57 | |
| Earnings yield | -0.04 | -0.02 | -0.01 | 0 | -0.03 | |
| Free cash flow yield | 0 | -0.02 | 0 | 0 | 0 | |
| Debt to equity | 2.05 | 2.48 | 2.51 | 2.98 | 3.45 | |
| Debt to assets | 0.74 | 0.79 | 0.8 | 0.85 | 0.9 | |
| Net debt to EBITDA | -7.12 | -12.89 | -137.25 | -22.52 | -13.16 | |
| Current ratio | 0.58 | 0.57 | 0.58 | 0.53 | 0.5 | |
| Interest coverage | -10.99 | -8.58 | 0.36 | -10.21 | -8.51 | |
| Income quality | 0 | 0 | 0 | 0 | 0 | |
| Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
| Payout ratio | -0.07 | -0.09 | -0.52 | -0.1 | -0.13 | |
| Sales general and administrative to revenue | 0.09 | -0.02 | 0.11 | -0.08 | 0.05 | |
| Research and developement to revenue | 0 | 0.01 | 0 | 0 | 0 | |
| Intangibles to total assets | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | |
| Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
| Capex to revenue | 0 | -0.09 | -0.02 | -0.03 | -0.02 | |
| Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 2.43 | 1.74 | 0.95 | 0 | 1.66 | |
| ROIC | -0.1 | -0.06 | 0 | -0.07 | -0.09 | |
| Return on tangible assets | -0.08 | -0.04 | -0.01 | -0.06 | -0.06 | |
| Graham Net | -1.66 | -1.74 | -1.72 | 0 | -1.81 | |
| Working capital | -218.09M | -253.45M | -243.36M | -298.66M | -325.7M | |
| Tangible asset value | 186.61M | 151.64M | 139.37M | 91.06M | 50.69M | |
| Net current asset value | -308.44M | -344.95M | -322.95M | -343.19M | -365.27M | |
| Invested capital | 1.5 | 1.89 | 1.91 | 2.12 | 2.22 | |
| Average receivables | 0 | 0 | 0 | 0 | 0 | |
| Average payables | 82.86M | 86.21M | 90.45M | 93.63M | 78.79M | |
| Average inventory | 226.5M | 217.9M | 208.57M | 213.32M | 195.33M | |
| Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
| Days payables outstanding | 31.09 | 28.01 | 26.56 | 28.09 | 19.58 | |
| Days of inventory on hand | 82.98 | 67.02 | 59.06 | 65.51 | 52.86 | |
| Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
| Payables turnover | 2.89 | 3.21 | 3.39 | 3.2 | 4.6 | |
| Inventory turnover | 1.08 | 1.34 | 1.52 | 1.37 | 1.7 | |
| ROE | -0.21 | -0.13 | -0.04 | -0.21 | -0.21 | |
| Capex per share | 0 | -0.1 | -0.02 | 0 | -0.02 |
000702.SZ Frequently Asked Questions
What is Hunan Zhenghong Science and Technology Develop Co.,Ltd. stock symbol ?
Hunan Zhenghong Science and Technology Develop Co.,Ltd. is a CN stock and trading under the symbol 000702.SZ
What is Hunan Zhenghong Science and Technology Develop Co.,Ltd. stock quote today ?
Hunan Zhenghong Science and Technology Develop Co.,Ltd. stock price is $5.18 today.
Is Hunan Zhenghong Science and Technology Develop Co.,Ltd. stock public?
Yes, Hunan Zhenghong Science and Technology Develop Co.,Ltd. is a publicly traded company.
Company Profile
- Volume Average 6.46M
- Market Capitalization 1.38B
- Employee 1.01K
- CEO Mr. Yufei Yang
- Headquarters Yueyang,CN
- IPO Date 1997-03-18
-
Website
https://www.chinazhjt.com.cn 
Hunan Zhenghong Science and Technology Develop Co.,Ltd. researches, develops, produces, and sells feed products under the Zhenghong brand in China. The company offers a series of feed products primarily for pigs, chickens, ducks, fishes, cattle, and sheep. It is also involved in pig breeding, meat processing, biological veterinary drugs manufacturing, and import and export trade businesses. The company is based in Yueyang, China.
